Thermo Fisher Scientific Inc

Thermo Fisher Scientific Inc. Shs Cert Deposito Arg Repr 0.0454545 Sh's next confirmed earnings release is scheduled for February 4, 2027.

As of June 30, 2026, Thermo Fisher Scientific Inc. Shs Cert Deposito Arg Repr 0.0454545 Sh has 7.66B shares outstanding.

As of June 30, 2026, Thermo Fisher Scientific Inc. Shs Cert Deposito Arg Repr 0.0454545 Sh maintains a current ratio of 1.55, meaning it holds 1.6x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 80.57, indicating elevated leverage, while an interest coverage ratio of 7.56 demonstrates adequate ability to service its debt obligations.

Over the twelve months ended June 30, 2026, Thermo Fisher Scientific Inc. Shs Cert Deposito Arg Repr 0.0454545 Sh posted a return on equity (ROE) of 13.50, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 8.30 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 6.50, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 9.16, useful for judging operating efficiency across full business cycles. The company generates approximately 370,688.00 in revenue per employee across its workforce of 125,000.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 4.90 indicates how many times Thermo Fisher Scientific Inc. Shs Cert Deposito Arg Repr 0.0454545 Sh sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, Thermo Fisher Scientific Inc. Shs Cert Deposito Arg Repr 0.0454545 Sh recorded 597.00M in income tax expense. That works out to an effective tax rate of 7.82, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 7.64B, leaving 6.97B in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

Over the twelve months ended June 30, 2026, Thermo Fisher Scientific Inc. Shs Cert Deposito Arg Repr 0.0454545 Sh generated 46.34B in revenue and converted that into 6.97B in net income, yielding earnings per share of 0.90. EBITDA reached 11.09B, while operating income came in at 8.48B.

As of June 30, 2026, Thermo Fisher Scientific Inc. Shs Cert Deposito Arg Repr 0.0454545 Sh holds 4.06B in cash and equivalents against 42.55B in total debt, resulting in a net debt position of 38.49B. Total book value stands at 52.68B, with working capital of 8.30B providing operational flexibility.

Thermo Fisher Scientific Inc. Shs Cert Deposito Arg Repr 0.0454545 Sh produced 9.01B in operating cash flow over the twelve months ended June 30, 2026. After subtracting -1.69B in capital expenditures, free cash flow totaled 7.32B - equivalent to 0.94 per share.

Over the twelve months ended June 30, 2026, Thermo Fisher Scientific Inc. Shs Cert Deposito Arg Repr 0.0454545 Sh posted a gross margin of 40.80, reflecting its pricing power and cost economics. The operating margin of 18.29 and net profit margin of 15.04 provide insight into operational efficiency.

Over the twelve months ended June 30, 2026, Thermo Fisher Scientific Inc. Shs Cert Deposito Arg Repr 0.0454545 Sh paid dividends of 0.09 per share. The dividend payout ratio of 9.44 indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth.

Thermo Fisher Scientific Inc. Shs Cert Deposito Arg Repr 0.0454545 Sh's most recent stock split took place on October 22, 2020 with a 1:2 split ratio.